Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry
Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2024
DOI: 10.1089/mab.2023.0014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2024. Verfasst von Tsunenori Ouchida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Immune checkpoint blockade therapy has shown successful clinical outcomes in multiple human cancers. In dogs, several types of tumors resemble human tumors in many respects. Therefore, several groups have developed the anti-dog programmed cell death ligand 1 (dPD-L1) monoclonal antibodies (mAbs) and showed efficacy in several canine tumors. To examine the abundance of dPD-L1 in canine tumors, anti-dPD-L1 diagnostic mAbs for immunohistochemistry are required. In this study, we immunized the peptide in the dPD-L1 intracellular domain, and established anti-dPD-L1 mAbs, L 1 Mab-352 (mouse IgG 1 , kappa), and L 1 Mab-354 (mouse IgG 1 , kappa). In enzyme-linked immunosorbent assay, L 1 Mab-352 and L 1 Mab-354 showed high-binding affinity to the dPD-L1 peptide, and the dissociation constants ( K D ) were determined as 6.9 × 10 −10 M and 7.2 × 10 −10 M, respectively. Furthermore, L 1 Mab-352 and L 1 Mab-354 were applicable for the detection of dPD-L1 in immunohistochemical analysis in paraffin-embedded dPD-L1-overexpressed cells. These results indicated that L 1 Mab-352 and L 1 Mab-354 are useful for detecting dPD-L1 in immunohistochemical analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Yukinari Kato
Zitieren
APA
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2024). Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2023.0014
Vancouver
Ouchida T, Suzuki H, Tanaka T, Kaneko MK, Kato Y. Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2024. doi:10.1089/mab.2023.0014
BibTeX
@article{Ouchida2024,
author = {Ouchida, Tsunenori and Suzuki, Hiroyuki and Tanaka, Tomohiro and Kaneko, Mika K and Kato, Yukinari},
title = {Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry},
journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
year = {2024},
doi = {10.1089/mab.2023.0014}
}
EUVIMED